持续葡萄糖监测对老年1型糖尿病低血糖感知受损的影响:WISDM研究的事后分析
该事后分析基于WISDM研究,评估持续葡萄糖监测(CGM)使用52周对老年1型糖尿病患者低血糖感知受损(IAH)的影响。结果显示,使用CGM 26周和52周后Clarke-SHEF显著下降,但Clarke-full和Clarke-HAF无变化;52周后IAH亚组中Clarke-full改善而Clarke-HAF未改善,提示IAH改善因评分方法而异。
要点
- 老年1型糖尿病患者使用CGM可改善严重低血糖经历因子(Clarke-SHEF)。
- CGM对低血糖感知受损的改善因评分方法不同而异。
- Clarke-full评分在IAH亚组中52周后改善,但Clarke-HAF未改善。
核心结论
- 在老年1型糖尿病患者中,CGM改善低血糖,但对低血糖感知受损的作用因评分方法而异,凸显Clarke评分的局限性。
研究设计与样本
- WISDM研究的事后分析,聚焦CGM使用52周,在基线、26周和52周评估IAH。
主要发现
- 使用CGM 26周(n=184)和52周(n=94)后,Clarke-SHEF显著下降(P=0.02和P<0.0001)。
- Clarke-full和Clarke-HAF在26周和52周均无显著变化。
- 52周后,IAH亚组中Clarke-full改善,但Clarke-HAF未改善。
关键数值与推荐
- IAH评估采用Clarke原始评分(Clarke-full)及其子量表低血糖感知因子(HAF)和严重低血糖经历因子(SHEF)。
临床怎么用
- 老年1型糖尿病患者使用CGM可能减少严重低血糖经历,但评估低血糖感知受损需注意评分方法的选择。
局限性
- 事后分析,样本量在52周时为94例,可能存在选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Although continuous glucose monitoring (CGM) reduces hypoglycemia and may improve impaired awareness of hypoglycemia (IAH), its effectiveness in older adults at high risk remains unknown. RESEARCH DESIGN AND METHODS: This post hoc analysis of the WISDM study focuses on CGM use over 52 weeks. IAH was assessed using the Clarke original score (Clarke-full) and its subscales, Hypoglycemia Awareness Factor (HAF) and Severe Hypoglycemia Experienced Factors (SHEF), at baseline, 26 weeks, and 52 weeks. RESULTS: After 26 weeks (n = 184) and 52 weeks (n = 94) of CGM use, Clarke-SHEF decreased significantly (P = 0.02 and P < 0.0001, respectively), whereas Clarke-full and Clarke-HAF remained unchanged. After 52 weeks, Clarke-full but not Clarke-HAF improved in the IAH subgroup, highlighting the importance of selecting the appropriate scoring method for IAH. CONCLUSIONS: In older adults with type 1 diabetes, CGM improves hypoglycemia; however, its role in improving IAH is variable, depending on the scoring method. This study highlights the limitations of the Clarke score.
引用
- Bilal A, Yi F, Whitaker K, et al. Effects of Continuous Glucose Monitoring on Impaired Awareness of Hypoglycemia in Older Adults With Type 1 Diabetes: A Post Hoc Analysis of the WISDM Study. Diabetes Care. 2026. PMID: 40902121. doi:10.2337/dc25-0971
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。